Literature DB >> 18815146

Acute exercise protects against doxorubicin cardiotoxicity.

Karen Y Wonders1, David S Hydock, Carole M Schneider, Reid Hayward.   

Abstract

UNLABELLED: Numerous methods have been used to minimize the cardiotoxic effects of the chemotherapeutic agent doxorubicin (DOX), and most have had limited success. Chronic endurance exercise has been shown to protect against DOX cardiotoxicity, but little is known regarding the effects of acute exercise on DOX-induced cardiac dysfunction.
PURPOSE: The purpose of this study was to determine the effects of a single bout of acute endurance exercise on the cardiac dysfunction associated with DOX treatment.
METHODS: Male Sprague-Dawley rats either performed an acute exercise bout on a motorized treadmill for 60 minutes at a maximal speed of 25 m/min with a 5% grade (EX) or remained sedentary (SED) 24 hours before receiving either a 15-mg/kg DOX bolus dose or saline (SAL). Cardiac function was then analyzed 5 days post injection using a Langendorff isolated perfused heart model. In addition, myocardial lipid peroxidation was analyzed as an indicator of oxidative stress.
RESULTS: Doxorubicin treatment alone (SED+DOX) promoted a significant decline in end-systolic pressure (-35%), left ventricular developed pressure (-59%), and the maximal rate of left ventricular pressure development (-43%) as well as a 45% increase in lipid peroxidation products when compared with SED+SAL (P<.05). Acute exercise 24 hours before DOX treatment, however, had a cardioprotective effect, as end-systolic pressure, left ventricular developed pressure, and the maximal rate of left ventricular pressure development were significantly higher in EX+DOX compared with SED+DOX (P<.05) and EX+DOX had similar levels of lipid peroxidation products as SED+SAL
CONCLUSIONS: An acute exercise bout performed 24 hours before DOX treatment protected against cardiac dysfunction, and this exercise-induced cardioprotection may partly be explained by a reduction in the generation of reactive oxygen species.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815146     DOI: 10.1177/1534735408322848

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  30 in total

Review 1.  Exercise therapy in the management of solid tumors.

Authors:  Lee W Jones; Jeffrey Peppercom; Jessica M Scott; Claudio Battaglini
Journal:  Curr Treat Options Oncol       Date:  2010-06

2.  Short-term exercise training attenuates acute doxorubicin cardiotoxicity.

Authors:  Chia-Ying Lien; Brock T Jensen; David S Hydock; Reid Hayward
Journal:  J Physiol Biochem       Date:  2015-09-24       Impact factor: 4.158

Review 3.  Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms.

Authors:  Jessica M Scott; Aarif Khakoo; John R Mackey; Mark J Haykowsky; Pamela S Douglas; Lee W Jones
Journal:  Circulation       Date:  2011-08-02       Impact factor: 29.690

4.  Exercise stimulates beneficial adaptations to diminish doxorubicin-induced cellular toxicity.

Authors:  Ashley J Smuder
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-08-28       Impact factor: 3.619

5.  Patient preference and timing for exercise in breast cancer care.

Authors:  Kathleen M Sturgeon; Carla Fisher; Gina McShea; Susan Kruse Sullivan; Dahlia Sataloff; Kathryn H Schmitz
Journal:  Support Care Cancer       Date:  2017-08-24       Impact factor: 3.603

Review 6.  The effects of exercise on cardiovascular outcomes before, during, and after treatment for breast cancer.

Authors:  Kathleen M Sturgeon; Bonnie Ky; Joseph R Libonati; Kathryn H Schmitz
Journal:  Breast Cancer Res Treat       Date:  2013-12-14       Impact factor: 4.872

Review 7.  Exercise Training and Cardiovascular Health in Cancer Patients.

Authors:  Ray W Squires; Adam M Shultz; Joerg Herrmann
Journal:  Curr Oncol Rep       Date:  2018-03-10       Impact factor: 5.075

8.  Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats.

Authors:  Mohammad Sheibani; Sadaf Nezamoleslami; Hedyeh Faghir-Ghanesefat; Amir Hossein Emami; Ahmad Reza Dehpour
Journal:  Cancer Chemother Pharmacol       Date:  2020-01-08       Impact factor: 3.333

9.  Tissue retention of doxorubicin and its effects on cardiac, smooth, and skeletal muscle function.

Authors:  Reid Hayward; David Hydock; Noah Gibson; Stephanie Greufe; Eric Bredahl; Traci Parry
Journal:  J Physiol Biochem       Date:  2012-08-14       Impact factor: 4.158

10.  Aerobic Exercise During Early Murine Doxorubicin Exposure Mitigates Cardiac Toxicity.

Authors:  Fei Wang; Brian Iskra; Eugenie Kleinerman; Claudia Alvarez-Florez; Thomas Andrews; Angela Shaw; Joya Chandra; Keri Schadler; Gregory J Aune
Journal:  J Pediatr Hematol Oncol       Date:  2018-04       Impact factor: 1.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.